These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3685042)
41. Studies of the pathogenic mechanisms of light on rat retina. Lai YL; Lug R; Yao PC; Hayasaka S; Hayasaka I Acta Anat (Basel); 1980; 107(4):407-17. PubMed ID: 7405529 [No Abstract] [Full Text] [Related]
42. Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings. Rahi AH; Hungerford JL; Ahmed AI Br J Ophthalmol; 1986 May; 70(5):373-81. PubMed ID: 3964637 [TBL] [Abstract][Full Text] [Related]
43. [Pigmentary changes of the retina in dialysis patients treated with deferoxamine]. Mathys B; Baeck A; Verougstraete C; Verstappen A; D'Haene M; Zanen A Bull Soc Belge Ophtalmol; 1988; 229():49-60. PubMed ID: 3273254 [No Abstract] [Full Text] [Related]
44. Neural retinal and pigment epithelial cells in culture: patterns of differentiation and effects of prostaglandins and cyclic-AMP on pigmentation. Redfern N; Israel P; Bergsma D; Robison WG; Whikehart D; Chader G Exp Eye Res; 1976 May; 22(5):559-68. PubMed ID: 179835 [No Abstract] [Full Text] [Related]
45. Down-regulation of senescence marker protein 30 by iron-specific chelator deferoxamine drives cell senescence. Inoue H; Hanawa N; Katsumata-Tsuboi R; Katsumata SI; Takahashi N; Uehara M Biosci Biotechnol Biochem; 2018 May; 82(5):900-903. PubMed ID: 29490582 [TBL] [Abstract][Full Text] [Related]
46. Antioxidant and iron-chelating agents in cerebral vasospasm. Luo Z; Harada T; London S; Gajdusek C; Mayberg MR Neurosurgery; 1995 Dec; 37(6):1154-8; discussion 1158-9. PubMed ID: 8584156 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of retinal susceptibility to light damage in pigmented rats supplemented with beta-carotene. Rapp LM; Fisher PL; Suh DW Curr Eye Res; 1996 Feb; 15(2):219-23. PubMed ID: 8670732 [TBL] [Abstract][Full Text] [Related]
48. The severity of copper deficiency can be ameliorated by deferoxamine. Fields M; Lewis CG; Lure MD; Burns WA; Antholine WE Metabolism; 1991 Jan; 40(1):105-9. PubMed ID: 1845818 [TBL] [Abstract][Full Text] [Related]
49. [Effect of argon laser photoradiation on the monkey retina treated with hematoporphyrin derivative--an electron microscopic study]. Ohnishi Y; Yamana Y; Ishibashi T Nippon Ganka Gakkai Zasshi; 1984 Nov; 88(11):1389-96. PubMed ID: 6543289 [No Abstract] [Full Text] [Related]
50. Iron chelator deferoxamine induces epithelial transformation of tumor cells. Rubtsova SN; Vasilev YM Dokl Biol Sci; 2006; 411():517-9. PubMed ID: 17425058 [No Abstract] [Full Text] [Related]
52. Changes in ultrastructure and function of the sheep pigment epithelium and retina induced by sodium iodate. III. Delayed effects. Nilsson SE; Knave B; Persson HE Acta Ophthalmol (Copenh); 1977 Dec; 55(6):1027-43. PubMed ID: 579542 [No Abstract] [Full Text] [Related]
53. Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro. Kovár J; Kemp JD In Vitro Cell Dev Biol Anim; 2000 Mar; 36(3):151-2. PubMed ID: 10777053 [No Abstract] [Full Text] [Related]
57. Pigment aggregation by melatonin in the retinal pigment epithelium and choroid of guinea-pigs, Caviaporcellus. Pang SF; Yew DT Experientia; 1979 Feb; 35(2):231-3. PubMed ID: 421842 [No Abstract] [Full Text] [Related]
58. [Animal experiment studies of the retinotoxic effect of low-level lead concentrations]. Hennekes R; Janssen K Fortschr Ophthalmol; 1987; 84(4):374-6. PubMed ID: 3666633 [No Abstract] [Full Text] [Related]
59. Desferrioxamine administered intravenously by infusion causes a reduction in the electroretinogram in rabbits anaesthetized with urethane. Arden GB Hum Toxicol; 1986 Jul; 5(4):229-36. PubMed ID: 3733112 [TBL] [Abstract][Full Text] [Related]
60. Toxic effects of ornithine and its related compounds on the retina. Ishikawa Y; Kuwabara T; Kaiser-Kupfer MI Adv Exp Med Biol; 1982; 153():371-8. PubMed ID: 6131576 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]